Ömer BOZDOĞAN

8596

Effect of the Combination of Glibenclamide, an ATP-dependent Potassium Channel Blocker, and Metoprolol, a Cardioselective b-adrenoceptor Blocker, During Myocardial Infarction in Conscious Rats

We investigated the possible interaction of glibenclamide and metoprolol on the occurrence of life threatening arrhythmias during the acute phase of experimental myocardial infarction. Coronary artery ligation was performed in conscious rats and ECG was recorded for 15 min following ligation. Neither metoprolol (2 mg/kg i.p., 20 min before coronary artery ligation), nor glibenclamide (5 mg/kg i.p., 30 min before ligation) pretreatment increased significantly the survival rate during the acute phase of myocardial infarction (10 % and 22 %, respectively vs. 9 % in controls). Combination of glibenclamide with metoprolol, however, significantly improved the survival rate (62 %, P < 0.05). These results suggest that the combination of a cardioselective b-blocking agent with an ATP- dependent potassium channel inhibitor may result in an enhanced antiarrhythmic effect during the acute phase of myocardial infarction.
Anahtar Kelimeler:

Glibenclamide, Metoprolol, Arrhythmias, Sudden cardiac death, Conscious rats

Effect of the Combination of Glibenclamide, an ATP-dependent Potassium Channel Blocker, and Metoprolol, a Cardioselective b-adrenoceptor Blocker, During Myocardial Infarction in Conscious Rats

We investigated the possible interaction of glibenclamide and metoprolol on the occurrence of life threatening arrhythmias during the acute phase of experimental myocardial infarction. Coronary artery ligation was performed in conscious rats and ECG was recorded for 15 min following ligation. Neither metoprolol (2 mg/kg i.p., 20 min before coronary artery ligation), nor glibenclamide (5 mg/kg i.p., 30 min before ligation) pretreatment increased significantly the survival rate during the acute phase of myocardial infarction (10 % and 22 %, respectively vs. 9 % in controls). Combination of glibenclamide with metoprolol, however, significantly improved the survival rate (62 %, P < 0.05). These results suggest that the combination of a cardioselective b-blocking agent with an ATP- dependent potassium channel inhibitor may result in an enhanced antiarrhythmic effect during the acute phase of myocardial infarction.
Keywords:

Glibenclamide, Metoprolol, Arrhythmias, Sudden cardiac death, Conscious rats,

PDF
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Tradive dystonia or tardive myoclonus

Hatice BALABAN, Muhittin Cenk AKBOSTANCI, Cem ATBAŞOĞLU, Ali Kemal GÖĞÜŞ

Mechanical and Thermal Properties of Hydroxyapatite-Impregnated Bone Cement

Kemal ŞERBETÇİ

Effect of the Combination of Glibenclamide, an ATP-dependent Potassium Channel Blocker, and Metoprolol, a Cardioselective b-adrenoceptor Blocker, During Myocardial Infarction in Conscious Rats

Ömer BOZDOĞAN

Effects of Growth Hormone on Hepatic Regeneration

İ. Mahmut BAŞOĞLU, Cemal GÜNDOĞDU, Zekai ERMAN, İlhan YILDIRGAN, İbrahim KAVAK, Ahmet A. BALIK, Durkaya ÖREN

Biological Dosimetry Following X-ray Irradiation

Aslı TOP, Münevver COŞKUN, Tuncay ORTA

Biosynthesis of Polyhydroxybutyrate and its Copolymers and Their Use in Controlled Drug Release

Füsun TÜRESİN, Vasıf HASIRCI, Fatma N. KÖK, İhsan GÜRSEL, N. Gürdal ALAADDİNOĞLU, Zeynep GÜMÜŞYAZICI

Detection of cystic fibrosis $Delta$F508 mutation in the Çukurova region

Tamer Cevat İNAL, Güler ÖZER, Bilgin YÜKSEL, Güneş YÜREGİR

Histopathological Effects of Cholesterol and Protective Effects of Vitamin E and Selenium on the Morphology of Liver

Melda YARDIMOĞLU, Süheyla GONCA, Süreyya CEYLAN, Hakkı DALÇIK, Sibel KÖKTÜRK, Zühal YUMBUL, Serdar FİLİZ

The effect of levonorgestrel and melatonin treatments on plasma oxidant-antioxidant system, and lipid / lipoprotein levels in female rats

Cevad YAZICI, Kader KÖSE

Effect of the combination of glibenclamide, an ATP-dependent potassium channel blocker, and metoprolol, a cardioselective $beta$-adrenoceptor blocker, during myocardial infarction in conscious rats

Ömer BOZDOĞAN, Istvan LEPRAN, Julius Gy. PAPP